Certara Executive and Leadership Team

William Feehery, the Chief Executive Officer at Certara, directs the company's overall strategic vision and operational execution. Feehery guides Certara's mission to accelerate the development of medicines by leveraging advanced software, AI platforms, and scientific consulting. Overseeing the integration of model-informed drug development (MIDD) and biosimulation technologies, Feehery ensures these tools effectively predict drug behavior and optimize clinical outcomes. This leadership involves fostering innovation across all departments, driving the company's market position in the biopharmaceutical services sector. William Feehery's focus remains on enhancing the value delivered to clients throughout the entire drug development lifecycle, from initial discovery through to market access. The Chief Executive Officer's role encompasses ensuring robust financial performance and sustainable growth, aligning departmental objectives with the overarching corporate strategy. Feehery's executive oversight extends to cultivating key partnerships and maintaining Certara's reputation as a leader in scientific advancement.

Faiz Mohammed, the Interim Chief Financial Officer. at Certara, manages the company's financial operations and strategic fiscal planning. Mohammed oversees all aspects of financial reporting, budgeting, forecasting, and capital allocation, ensuring fiscal health and supporting growth initiatives. This role involves providing critical financial insights to guide executive decision-making across the drug development lifecycle. Faiz Mohammed's responsibilities include optimizing financial performance, managing investor relations, and ensuring compliance with all financial regulations. The Interim Chief Financial Officer. plays a key part in evaluating potential investments and strategic partnerships that align with Certara's mission of accelerating medicine development. Mohammed's leadership ensures that financial resources are effectively deployed to support the company's AI-driven platforms, biosimulation technologies, and scientific consulting services. By maintaining rigorous financial discipline, Faiz Mohammed strengthens Certara's ability to deliver value and achieve its long-term objectives in the biopharmaceutical sector.

Martin Snyder, the President, Certara Data Sciences at Certara, directs the strategic vision and operational execution for the company's data science initiatives. Snyder leads the development and application of advanced analytics and AI-driven platforms that enhance model-informed drug development (MIDD) and biosimulation technologies. This leadership involves leveraging complex datasets to predict drug behavior and optimize clinical outcomes across the drug development lifecycle. Martin Snyder's focus is on driving innovation in data science to provide clients with deeper insights and more effective R&D solutions. The President, Certara Data Sciences' responsibilities include overseeing teams of data scientists and engineers, ensuring the quality and impact of their work. Snyder's expertise is crucial in translating raw data into actionable intelligence that accelerates the discovery and development of new medicines. By championing data-driven approaches, Martin Snyder strengthens Certara's position as a leader in scientific consulting and technology services.

Adrian McKemey, the President, Certara Drug Development Solutions at Certara, leads the comprehensive suite of services designed to accelerate medicine development. McKemey oversees the strategic direction and delivery of solutions that span the entire drug lifecycle, from discovery through to market access. This leadership role emphasizes the integration of Certara's software, AI platforms, and scientific consulting, particularly its core strength in model-informed drug development (MIDD) and biosimulation. Adrian McKemey ensures that clients receive expert guidance in predicting drug behavior and optimizing clinical outcomes. The President, Certara Drug Development Solutions' responsibilities include fostering collaboration among scientific teams and driving operational excellence. McKemey's focus is on enhancing the value and impact of Certara's offerings, enabling pharmaceutical and biotechnology companies to bring novel therapies to patients more efficiently. By championing innovative approaches, Adrian McKemey solidifies Certara's role as a critical partner in global drug development.

Leif Pedersen, the President & Chief Commercial Officer at Certara, drives the company's global commercial strategy and revenue growth. Pedersen oversees all sales, business development, and customer engagement activities, ensuring Certara's software, AI platforms, and scientific consulting services effectively reach and serve clients worldwide. This leadership role is critical in expanding market share and solidifying Certara's position as a leader in model-informed drug development (MIDD) and biosimulation. Leif Pedersen's focus is on building strong client relationships and understanding their evolving needs throughout the drug development lifecycle. The President & Chief Commercial Officer's responsibilities include leading the commercial teams, developing go-to-market strategies, and maximizing the impact of Certara's solutions in optimizing clinical outcomes. Pedersen's commercial acumen ensures that the company's innovative technologies and scientific expertise translate into tangible business success for its partners in the biopharmaceutical industry.

Sheila Rocchio, the Chief Marketing Officer at Certara, architects and executes the global marketing strategy. Rocchio drives brand awareness and market penetration for Certara's comprehensive suite of software, AI-driven platforms, and scientific consulting services. This role involves translating the company's core strength in model-informed drug development (MIDD) and biosimulation into compelling market narratives that highlight optimized clinical outcomes. Sheila Rocchio oversees all demand generation activities, digital marketing initiatives, and corporate communications, ensuring consistent messaging across all channels. The Chief Marketing Officer's responsibilities include analyzing market trends, identifying new growth opportunities, and positioning Certara as the premier partner for drug development acceleration. Rocchio's leadership ensures that the company's innovative solutions are effectively communicated to pharmaceutical and biotechnology clients worldwide. By championing the value of biosimulation and predictive modeling, Sheila Rocchio directly supports the company's commercial objectives and strengthens its competitive advantage in the R&D services sector.

Chris Bouton, the Chief Technology Officer at Certara, spearheads the technological innovation and infrastructure supporting the company's software and AI-driven platforms. Bouton directs the development and enhancement of solutions used across the drug development lifecycle, from discovery to market access. This leadership involves ensuring the scalability, security, and performance of Certara's biosimulation and model-informed drug development (MIDD) technologies. Chris Bouton's purview includes overseeing the research and implementation of cutting-edge AI applications that predict drug behavior and optimize clinical outcomes. The Chief Technology Officer's role is critical in maintaining Certara's technological edge, driving advancements that empower clients to accelerate their R&D processes. Bouton's strategic vision guides the evolution of the company's technology stack, ensuring it remains at the forefront of scientific and computational capabilities. By fostering a culture of technical excellence, Chris Bouton enables the delivery of robust and innovative solutions to the biopharmaceutical industry.

Rona Anhalt, the Chief Human Resources Officer at Certara, leads the company's human capital strategy and organizational development. Anhalt focuses on attracting, retaining, and developing top talent essential for Certara's success in providing software, AI platforms, and scientific consulting. This leadership role involves cultivating a high-performance culture that supports innovation in model-informed drug development (MIDD) and biosimulation. Rona Anhalt oversees all HR functions, including talent acquisition, compensation and benefits, employee relations, and learning and development programs. The Chief Human Resources Officer's strategic input is vital for aligning the workforce with the company's mission to accelerate drug development and optimize clinical outcomes. Anhalt ensures that Certara's organizational structure and employee initiatives effectively support the delivery of advanced scientific services. By championing employee engagement and professional growth, Rona Anhalt strengthens the human element critical to Certara's technological and scientific advancements.